urea has been researched along with Cachexia in 13 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide treatment appeared to reverse the loss of weight and lean body mass over the 2-week trial period." | 6.71 | Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass. ( Austin, A; Cole, AT; Freeman, JG; Holt, M; Khan, ZH; MacDonald, I; Pye, D; Simpson, EJ, 2003) |
| " After 12 days of treatment, the tumor growth, some parameters of cachexia/anorexia, the blood levels of triacylglycerol, glucose, lactate and urea, the peripheral response to insulin and the hepatic glycolysis and gluconeogenesis were investigated." | 3.79 | Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats. ( Bazotte, RB; Borba-Murad, GR; da Rocha, AF; de Morais, H; de Souza, CO; de Souza, HM; Miksza, DR, 2013) |
| "Excessive urea excretion associated with a negative nitrogen balance and massive loss of skeletal muscle mass (cachexia) is a frequent life threatening complication in malignancies and HIV infection." | 3.69 | Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia. ( Berke, G; Bockstette, M; Dröge, W; Fiers, W; Gross, A; Hack, V; Kinscherf, R, 1996) |
| "Thalidomide treatment appeared to reverse the loss of weight and lean body mass over the 2-week trial period." | 2.71 | Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass. ( Austin, A; Cole, AT; Freeman, JG; Holt, M; Khan, ZH; MacDonald, I; Pye, D; Simpson, EJ, 2003) |
| "The urea cycle was evaluated in perfused livers isolated from cachectic tumor-bearing rats (Walker-256 tumor)." | 1.32 | The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats. ( Bracht, A; Constantin, J; Corbello Pereira, SR; da Silva, MH; Darronqui, E; Yamamoto, NS, 2004) |
| "Cancer cachexia is characterized by loss of lean body mass." | 1.30 | Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats. ( Boers, W; de Blaauw, I; Deutz, NE; von Meyenfeldt, MF, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Byard, RW | 1 |
| Martins, HA | 1 |
| Bazotte, RB | 3 |
| Vicentini, GE | 1 |
| Lima, MM | 1 |
| Guarnier, FA | 1 |
| Hermes-Uliana, C | 1 |
| Frez, FC | 1 |
| Bossolani, GD | 1 |
| Fracaro, L | 1 |
| Fávaro, LD | 1 |
| Manzano, MI | 1 |
| Zanoni, JN | 1 |
| Miksza, DR | 1 |
| de Souza, CO | 1 |
| de Morais, H | 1 |
| da Rocha, AF | 1 |
| Borba-Murad, GR | 2 |
| de Souza, HM | 2 |
| Padrão, AI | 1 |
| Moreira-Gonçalves, D | 1 |
| Oliveira, PA | 1 |
| Teixeira, C | 1 |
| Faustino-Rocha, AI | 1 |
| Helguero, L | 1 |
| Vitorino, R | 1 |
| Santos, LL | 1 |
| Amado, F | 1 |
| Duarte, JA | 1 |
| Ferreira, R | 1 |
| Rebeca, R | 1 |
| Bracht, L | 1 |
| Noleto, GR | 1 |
| Martinez, GR | 1 |
| Cadena, SM | 1 |
| Carnieri, EG | 1 |
| Rocha, ME | 1 |
| de Oliveira, MB | 1 |
| Cassolla, P | 1 |
| Moreira, CC | 1 |
| Liboni, TF | 1 |
| Zaia, CT | 1 |
| Khan, ZH | 1 |
| Simpson, EJ | 1 |
| Cole, AT | 1 |
| Holt, M | 1 |
| MacDonald, I | 1 |
| Pye, D | 1 |
| Austin, A | 1 |
| Freeman, JG | 1 |
| Corbello Pereira, SR | 1 |
| Darronqui, E | 1 |
| Constantin, J | 1 |
| da Silva, MH | 1 |
| Yamamoto, NS | 1 |
| Bracht, A | 1 |
| Llovera, M | 1 |
| García-Martínez, C | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Hack, V | 1 |
| Gross, A | 1 |
| Kinscherf, R | 1 |
| Bockstette, M | 1 |
| Fiers, W | 1 |
| Berke, G | 1 |
| Dröge, W | 1 |
| de Blaauw, I | 1 |
| Deutz, NE | 1 |
| Boers, W | 1 |
| von Meyenfeldt, MF | 1 |
| Beck, SA | 1 |
| Tisdale, MJ | 1 |
| Segar, WE | 1 |
| Novak, LP | 1 |
| Hawe, A | 1 |
| Rastelli, GC | 1 |
| Zehr, JE | 1 |
1 trial available for urea and Cachexia
| Article | Year |
|---|---|
Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.
Topics: Aged; Aged, 80 and over; Basal Metabolism; Body Composition; Body Mass Index; Cachexia; Energy Intak | 2003 |
12 other studies available for urea and Cachexia
| Article | Year |
|---|---|
Obstructive uropathy and unexpected death.
Topics: Aged; Cachexia; Creatinine; Death, Sudden; Dilatation, Pathologic; Humans; Hydronephrosis; Male; Pro | 2020 |
l-Glutamine supplementation promotes an improved energetic balance in Walker-256 tumor-bearing rats.
Topics: Animals; Blood Glucose; Cachexia; Carcinoma 256, Walker; Corticosterone; Dietary Supplements; Duoden | 2017 |
Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Blood Glucose; Cachexia; C | 2013 |
Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia.
Topics: Adaptation, Physiological; Animals; Apoptosis Regulatory Proteins; Cachexia; Cytokine TWEAK; Female; | 2015 |
Production of cachexia mediators by Walker 256 cells from ascitic tumors.
Topics: Animals; Arginase; Ascitic Fluid; Biogenic Polyamines; Cachexia; Carcinoma 256, Walker; Cell Line, T | 2008 |
Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake.
Topics: Animals; Anorexia; Cachexia; Carcinoma 256, Walker; Cholesterol; Fatty Acids, Nonesterified; Glycero | 2012 |
The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats.
Topics: Alanine; Ammonia; Animals; Cachexia; Carcinoma 256, Walker; In Vitro Techniques; Kinetics; Liver; Ma | 2004 |
The effect of chronic tumour necrosis factor-alpha treatment on urinary nitrogen excretion in the rat.
Topics: Animals; Biomarkers; Cachexia; Creatinine; Diaphragm; Disease Models, Animal; Female; Heart; Liver; | 1994 |
Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia.
Topics: Animals; Cachexia; Cysteine; Female; Fibrosarcoma; Glutamate-Cysteine Ligase; Glutathione; Interleuk | 1996 |
Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats.
Topics: Amino Acids; Animals; Cachexia; Female; Gluconeogenesis; Liver; Liver Circulation; Neoplasms, Experi | 1997 |
Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice.
Topics: Adenocarcinoma; Amino Acids; Animals; Cachexia; Colonic Neoplasms; Creatinine; Dietary Fats; Ketone | 1989 |
Body composition in mitral cachexia.
Topics: Angiocardiography; Animals; Blood Glucose; Blood Proteins; Blood Volume; Body Composition; Body Weig | 1971 |